Jundishapur Journal of Microbiology

Published by: Kowsar

Relationship Between Drug Resistance and cagA Gene in Helicobacter pylori

Reza Ghotaslou 1 , 2 , Morteza Milani 1 , 3 , * , Mohammad Taghi Akhi 2 , Mohammad Saeid Hejazi 4 , Mohammad Reza Nahaei 5 , Alka Hasani 2 and Yaeghob Sharifi 6
Authors Information
1 Liver and Gastroenterology Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Department of Microbiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 School of Advanced Medicine, Tabriz University of Medical Sciences, Tabriz, IR Iran
4 Department of Pharmaceutical Biotechnology, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, IR Iran
5 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
6 Department of Microbiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, IR Iran
Article information
  • Jundishapur Journal of Microbiology: December 01, 2013, 6 (10); e8480
  • Published Online: December 1, 2013
  • Article Type: Research Article
  • Received: October 8, 2012
  • Revised: January 11, 2013
  • Accepted: February 17, 2013
  • DOI: 10.5812/jjm.8480

To Cite: Ghotaslou R, Milani M, Akhi M T, Hejazi M S, Nahaei M R, et al. Relationship Between Drug Resistance and cagA Gene in Helicobacter pylori, Jundishapur J Microbiol. 2013 ; 6(10):e8480. doi: 10.5812/jjm.8480.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Algood HM, Cover TL. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev. 2006; 19(4): 597-613[DOI][PubMed]
  • 2. Rafeey M, Ghotaslou R, Nikvash S, Hafez AA. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother. 2007; 13(5): 291-5[DOI][PubMed]
  • 3. Erzin Y, Koksal V, Altun S, Dobrucali A, Aslan M, Erdamar S, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter. 2006; 11(6): 574-80[DOI][PubMed]
  • 4. Rick JR, Goldman M, Semino-Mora C, Liu H, Olsen C, Rueda-Pedraza E, et al. In situ expression of cagA and risk of gastroduodenal disease in Helicobacter pylori-infected children. J Pediatr Gastroenterol Nutr. 2010; 50(2): 167-72[DOI][PubMed]
  • 5. Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci. 2005; 96(12): 835-43[DOI][PubMed]
  • 6. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007; 56(6): 772-81[DOI][PubMed]
  • 7. Chuah SK, Tsay FW, Hsu PI, Wu DC. A new look at anti-Helicobacter pylori therapy. World J Gastroenterol. 2011; 17(35): 3971-5[DOI][PubMed]
  • 8. van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, de Boer WA. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut. 2000; 46(3): 321-6[PubMed]
  • 9. Agudo S, Perez-Perez G, Alarcon T, Lopez-Brea M. High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain. J Clin Microbiol. 2010; 48(10): 3703-7[DOI][PubMed]
  • 10. Ryan KA, van Doorn LJ, Moran AP, Glennon M, Smith T, Maher M. Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays. J Clin Microbiol. 2001; 39(5): 1978-80[DOI][PubMed]
  • 11. McNulty C, Owen R, Tompkins D, Hawtin P, McColl K, Price A, et al. Helicobacter pylori susceptibility testing by disc diffusion. J Antimicrob Chemother. 2002; 49(4): 601-9[PubMed]
  • 12. Boyanova L, Stancheva I, Spassova Z, Katzarov N, Mitov I, Koumanova R. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. J Med Microbiol. 2000; 49(5): 415-8[PubMed]
  • 13. Sambrook Joseph, Russell David W, Russell David W. Molecular cloning: a laboratory manual (3-volume set). 2001;
  • 14. Ko JS, Kim KM, Oh YL, Seo JK. cagA, vacA, and iceA genotypes of Helicobacter pylori in Korean children. Pediatr Int. 2008; 50(5): 628-31[DOI][PubMed]
  • 15. Podzorski Raymond P, Podzorski Diane S, Wuerth Ann, Tolia Vasundhara. Analysis of the vacA, cagA, cagE, iceA, and babA2 genes in Helicobacter pylori from sixty-one pediatric patients from the Midwestern United States. Diagnos Microbiol Infect Dis. 2003; 46(2): 83-88[DOI]
  • 16. Basset C, Holton J, Gatta L, Ricci C, Bernabucci V, Liuzzi G, et al. Helicobacter pylori infection: anything new should we know? Aliment Pharmacol Ther. 2004; 20 Suppl 2: 31-41[DOI][PubMed]
  • 17. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis. 2004; 10(6): 1088-94[DOI][PubMed]
  • 18. De Francesco V, Margiotta M, Zullo A, Hassan C, Valle ND, Burattini O, et al. Claritromycin resistance and Helicobacter pylori genotypes in Italy. J Microbiol. 2006; 44(6): 660-4[PubMed]
  • 19. Prazeres Magalhaes P, De Magalhaes Queiroz DM, Campos Barbosa DV, Aguiar Rocha G, Nogueira Mendes E, Santos A, et al. Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil. Antimicrob Agents Chemother. 2002; 46(6): 2021-3[PubMed]
  • 20. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut. 2004; 53(9): 1374-84[DOI][PubMed]
  • 21. Dore MP, Piana A, Carta M, Atzei A, Are BM, Mura I, et al. Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1998; 12(7): 635-9[PubMed]
  • 22. Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonca S, et al. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol. 2003; 3: 20[DOI][PubMed]
  • 23. Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter. 2000; 5(2): 79-83[PubMed]
  • 24. Milani Morteza, Ghotaslou Reza, Akhi Mohammad T, Nahaei Mohammad R, Hasani Alka, Somi Mohammad H, et al. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. J Infect Chemother. 2012; 18(6): 848-852
  • 25. Agudo S, Alarcon T, Cibrelus L, Urruzuno P, Martinez MJ, Lopez-Brea M. [High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children]. Rev Esp Quimioter. 2009; 22(2): 88-92[PubMed]
  • 26. Lobo Gatti L, Agostinho Jn F, De Labio R, Balbo Piason F, Carlos Da Silva L, Fagundez De Queiroz V, et al. Helicobacter pylori and cagA and vacA gene status in children from Brazil with chronic gastritis. Clin Exp Med. 2003; 3(3): 166-72[DOI][PubMed]
  • 27. Taneike I, Nami A, O'Connor A, Fitzgerald N, Murphy P, Qasim A, et al. Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status? Aliment Pharmacol Ther. 2009; 30(7): 784-90[DOI][PubMed]
  • 28. Chomvarin C, Namwat W, Chaicumpar K, Mairiang P, Sangchan A, Sripa B, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis. 2008; 12(1): 30-6[DOI][PubMed]
  • 29. Ortiz-Princz Diana, Guariglia-Oropeza Verónica, Ávila Maira, Correnti María, Perrone Marianella, Gutierrez Beatriz, et al. Helicobacter pylori cagA and vacA genotypes in Cuban and Venezuelan populations. Memórias do Instituto Oswaldo Cruz. 2010; 105(3): 331-335[DOI]
  • 30. Ghasemian SH, Tavakoli H, Mojtahed JF, Salehi Rasoul SB, Pishva E. Correlation of cagA positive Helicobacter pylori Infection with clinical outcomes in Alzahra hospital, Isfahan, Iran. J Res Med Sci. 2008; 13(4): 196-201
  • 31. Garcia Gabriella T, Aranda Katia RS, Gonçalves Manoel EP, Cardoso Silvia R, Iriya Kiyoshi, Silva Neusa P, et al. High prevalence of clarithromycin resistance and cagA, vacA, iceA2, and babA2 genotypes of Helicobacter pylori in Brazilian children. J Clin Microbiol. 2010; 48(11): 4266-4268
  • 32. Tao R, Fang PC, Liu HY, Jiang YS, Chen J. A new subtype of 3' region of cagA gene in Helicobacter pylori strains isolated from Zhejiang Province in China. World J Gastroenterol. 2004; 10(22): 3284-8[PubMed]
  • 33. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology. 2008; 135(1): 91-9[DOI][PubMed]
  • 34. Broutet N, Marais A, Lamouliatte H, de Mascarel A, Samoyeau R, Salamon R, et al. cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J Clin Microbiol. 2001; 39(4): 1319-22[DOI][PubMed]
  • 35. Karhukorpi J, Yan Y, Kolho KL, Rautelin H, Lahti M, Sirvio A, et al. cagA, vacA and iceA virulence genes of Helicobacter pylori isolates of children in Finland. Eur J Clin Microbiol Infect Dis. 2000; 19(10): 790-3[PubMed]
  • 36. Hussein NR, Mohammadi M, Talebkhan Y, Doraghi M, Letley DP, Muhammad MK, et al. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol. 2008; 46(5): 1774-9[DOI][PubMed]
  • 37. Elviss NC, Owen RJ, Breathnach A, Palmer C, Shetty N. Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000. J Med Microbiol. 2005; 54: 567-74[DOI][PubMed]
  • 38. Mirodzhov GK, Ishankulova DM, Dustov AD. [The frequency and resistance of cytotoxin-associated (CAG-A) Helicobacter pylori strains to antibacterial agents in chronic gastritis and duodenal ulcer]. Clin Med (Mosk). 2006; 84(5): 51-4
  • 39. Saruc M, Goksel G, Ozkaya S, Guclu F, Ozbakkaloglu B, Yuceyar H. The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey. Braz J Med Biol Res. 2001; 34(11): 1435-9[PubMed]
  • 40. Elviss NC, Owen RJ, Xerry J, Walker AM, Davies K. Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Chemother. 2004; 54(2): 435-40[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments